CATECHOL-O-METHYLTRANSFERASE AS A TARGET FOR MELANOMA DESTRUCTION

被引:10
|
作者
SMIT, NPM
LATTER, AJM
NAISHBYFIELD, S
WESTERHOF, W
PAVEL, S
RILEY, PA
机构
[1] UCL, UNIV COLL & MIDDLESEX SCH MED, DEPT CHEM PATHOL, LONDON W1P 6DB, ENGLAND
[2] BRUNEL UNIV, DEPT BIOL & BIOCHEM, UXBRIDGE UB8 3PH, MIDDX, ENGLAND
[3] LEIDEN UNIV HOSP, DEPT DERMATOL, 2300 RC LEIDEN, NETHERLANDS
关键词
CATECHOL-O-METHYLTRANSFERASE; MELANOMA CYTOTOXICITY; MELANOGENESIS; CATECHOLS; 4-HYDROXYANISOLE;
D O I
10.1016/0006-2952(94)90052-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Catechols may interfere in melanogenesis by causing increased levels of toxic quinones. Several catechols and known inhibitors of the enzyme catechol-O-methyltransferase (COMT) were therefore tested for their toxicity towards a pigmented melanoma cell line, UCLA-SO-(M14). The inhibition of thymidine incorporation as a result of exposure to the compounds was measured. All agents were compared to 4-hydroxyanisole (4HA), a depigmenting agent extensively studied as an antimelanoma drug. The compounds were also tested on the epithelial cell line, CNCM-I-(221) in the presence and absence of tyrosinase. All the compounds were more effective than 4HA towards the M14-cells at either 10(-4) M or 10(-5) M. The toxicity of 4HA towards the 221-cells was shown to be completely dependent on the presence of tyrosinase. Effects of the test agents on the 221-cells were also observed in the absence of tyrosinase. Although some of them were shown to be good substrates for tyrosinase only small changes in toxicity were observed as a result of the presence of the enzyme in comparison with 4HA. No direct correlation of the toxicity of the agents and COMT inhibition was observed. The possible mode of action of the compounds through inhibition of COMT and interference in melanogenesis is discussed together with other possibilities and factors involved.
引用
收藏
页码:743 / 752
页数:10
相关论文
共 50 条
  • [1] CATECHOL-O-METHYLTRANSFERASE
    FLOHE, L
    INTERNATIONAL PHARMACOPSYCHIATRY, 1974, 9 (01): : 52 - 60
  • [2] CATECHOL-O-METHYLTRANSFERASE IN VITILIGO
    LEPOOLE, IC
    VANDENWIJNGAARD, RMJGJ
    SMIT, NPM
    OOSTING, J
    WESTERHOF, W
    PAVEL, S
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1994, 286 (02) : 81 - 86
  • [3] Inhibitors of Catechol-O-Methyltransferase
    Barrow, James C.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (03) : 324 - 332
  • [4] CATECHOL-O-METHYLTRANSFERASE IN VITILIGO
    LEPOOLE, IC
    VANDENWIJNGAARD, RMJGJ
    SMITH, NPM
    OOSTING, H
    WESTERHOF, W
    PAVEL, S
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 456 - 456
  • [5] Catechol-O-methyltransferase, a new target for pancreatic cancer therapy
    Wu, Wenming
    Wu, Qiao
    Hong, Xiafei
    Zhou, Li
    Zhang, Jie
    You, Lei
    Wang, Wenze
    Wu, Huanwen
    Dai, Hongmei
    Zhao, Yupei
    CANCER SCIENCE, 2015, 106 (05) : 576 - 583
  • [6] Induction of cytotoxicity in melanoma cells through inhibition of catechol-O-methyltransferase
    Smit, NPM
    Pavel, S
    BIOCHEMICAL PHARMACOLOGY, 1995, 50 (12) : 1955 - 1962
  • [7] Inhibition of catechol-O-methyltransferase (COMT) as a tool for therapy of malignant melanoma
    Borovansky, J
    Smit, NPM
    Pavel, S
    CHEMICKE LISTY, 1996, 90 (09): : 653 - 654
  • [8] INHIBITION OF CATECHOL-O-METHYLTRANSFERASE BY FLAVONOIDS
    GUGLER, R
    DENGLER, HJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1972, 274 : R45 - &
  • [9] FLUORIMETRIC ASSAY FOR CATECHOL-O-METHYLTRANSFERASE
    OKADA, Y
    ZAITSU, K
    OHTSUBO, K
    NOHTA, H
    OHKURA, Y
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1981, 29 (06) : 1670 - 1673
  • [10] Catechol-O-methyltransferase polymorphism in ADHD
    Smolen, TN
    Smolen, A
    Willcutt, E
    BEHAVIOR GENETICS, 2004, 34 (06) : 660 - 661